Regional brain metabolism and treatment response in panic disorder patients: An [F]FDG-PET study

Neuropsychobiology

Volumn 66, Issue 2, 2012, Pages 106-111

  Kang, Eun Ho ^a   Park, Joo Eon ^c   Lee, Kyung Han ^a   Cho, Young Seok ^b   Kim, Jae Jin ^b   Yu, Bum Hee ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Keyo Hospital   (South Korea)

Author keywords

Escitalopram; Fluorodeoxyglucose PET; Neocortical function; Panic disorder; Selective serotonin reuptake inhibitors; Treatment response

Indexed keywords

ESCITALOPRAM; FLUORODEOXYGLUCOSE F 18;

ADULT; AMYGDALOID NUCLEUS; ARTICLE; BRAIN METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FRONTAL CORTEX; FRONTAL GYRUS; GLUCOSE METABOLISM; HUMAN; MALE; NEUROIMAGING; OUTCOME ASSESSMENT; PANIC; PARAHIPPOCAMPAL GYRUS; POSITRON EMISSION TOMOGRAPHY; PRECUNEUS; PRIORITY JOURNAL; TEMPORAL CORTEX; TREATMENT DURATION; TREATMENT RESPONSE; VOXEL BASED MORPHOMETRY;

ADULT; BRAIN; CASE-CONTROL STUDIES; CITALOPRAM; FEMALE; FLUORODEOXYGLUCOSE F18; FRONTAL LOBE; GLUCOSE; GYRUS CINGULI; HUMANS; LIMBIC SYSTEM; MALE; MIDDLE AGED; NEOCORTEX; PANIC DISORDER; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SEROTONIN UPTAKE INHIBITORS; TEMPORAL LOBE; TREATMENT OUTCOME;

EID: 84863863266     PISSN: 0302282X     EISSN: 14230224     Source Type: Journal    
DOI: 10.1159/000337740     Document Type: Article

References (33)

1. Kessler RC, Chiu WT, Jin R, Ruscio AM, Shear K, Walters EE: The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2006; 63: 415-424.
2. Kroenke K, Spitzer RL, Williams JB, Monahan PO, Lowe B: Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med 2007; 146: 317-325. (Pubitemid 351650592)
3. Kawachi I, Colditz GA, Ascherio A, Rimm EB, Giovannucci E, Stampfer MJ, Willett WC: Prospective study of phobic anxiety and risk of coronary heart disease in men. Circulation 1994; 89: 1992-1997. (Pubitemid 24142773)
4. Smoller JW, Pollack MH, Wassertheil-Smoller S, Jackson RD, Oberman A, Wong ND, Sheps D: Panic attacks and risk of incident cardiovascular events among postmenopausal women in the Women's Health Initiative Observational Study. Arch Gen Psychiatry 2007; 64: 1153-1160. (Pubitemid 47529339)
5. Albert CM, Chae CU, Rexrode KM, Manson JE, Kawachi I: Phobic anxiety and risk of coronary heart disease and sudden cardiac death among women. Circulation 2005; 111: 480-487. (Pubitemid 40204433)
6. Malhi GS, Lagopoulos J: Making sense of neuroimaging in psychiatry. Acta Psychiatr Scand 2008; 117: 100-117.
7. Reiman EM, Raichle ME, Butler FK, Herscovitch P, Robins E: A focal brain abnormality in panic disorder, a severe form of anxiety. Nature 1984;310:683-685. (Pubitemid 14054331)
8. Nordahl TE, Semple WE, Gross M, Mellman TA, Stein MB, Goyer P, King AC, Uhde TW, Cohen RM: Cerebral glucose metabolic differences in patients with panic disorder. Neuropsychopharmacol 1990;3:261-272. (Pubitemid 20251523)
9. De Cristofaro MT, Sessarego A, Pupi A, Biondi F, Faravelli C: Brain perfusion abnormalities in drug-naive, lactate-sensitive panic patients: a SPECT study. Biol Psychiatry 1993; 33: 505-512. (Pubitemid 23167216)
10. Bisaga A, Katz JL, Antonini A, Wright CE, Margouleff C, Gorman JM, Eidelberg D: Cerebral glucose metabolism in women with panic disorder. Am J Psychiatry 1998;155: 1178-1183. (Pubitemid 28402509)
11. Prasko J, Horacek J, Zalesky R, Kopecek M, Novak T, Paskova B, Skrdlantova L, Belohlavek O, Hoschl C: The change of regional brain metabolism ( 18 FDG PET) in panic disorder during the treatment with cognitive behavioral therapy or antidepressants. Neuro Endocrinol Lett 2004; 25: 340-348. (Pubitemid 39625042)
12. Bruce SE, Yonkers KA, Otto MW, Eisen JL, Weisberg RB, Pagano M, Shea MT, Keller MB: Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: a 12-year prospective study. Am J Psychiatry 2005; 162: 1179-1187. (Pubitemid 40770702)
13. Gorman JM, Kent JM, Sullivan GM, Coplan JD: Neuroanatomical hypothesis of panic disorder, revised. Am J Psychiatry 2000; 157: 493-505. (Pubitemid 30191187)
14. Zhou L, Huang KX, Kecojevic A, Welsh AM, Koliatsos VE: Evidence that serotonin reuptake modulators increase the density of serotonin innervation in the forebrain. J Neurochem 2006; 96: 396-406.
15. Lim YJ, Yu BH, Kim JH: Korean panic disorder severity scale: construct validity by confirmatory factor analysis. Depress Anxiety 2007; 24: 95-102.
16. Oldfield RC: The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 1971; 9: 97-113.
17. First MB, Spitzer RL, Gibbon M, Williams JBW: Structured Clinical Interview for DSM-IV Axis I Disorders. New York, New York State Psychiatric Institute, 1996.
18. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56-62.
19. Hamilton M: The assessment of anxiety states by rating. Br J Med Psychol 1959; 32: 50-55.
20. Spielberger CD, Gorsuch RL, Lushene RE: Manual for the State Trait Anxiety Inventory. Palo Alto, Consulting Psychologists Press, 1970.
21. Mueller CA, Weinmann W, Dresen S, Schreiber A, Gergov M: Development of a multitarget screening analysis for 301 drugs using a QTrap liquid chromatography/tandem mass spectrometry system and automated library searching. Rapid Commun Mass Spectrom 2005; 19: 1332-1338. (Pubitemid 40728148)
22. Talairach J, Tournoux P: Co-Planar Stereotaxic Atlas of the Human Brain. New York, Thieme, 1988.
23. Kim JJ, Kwon JS, Park HJ, Youn T, Kang DH, Kim MS, Lee DS, Lee MC: Functional disconnection between the prefrontal and parietal cortices during working memory processing in schizophrenia: a [ 15 O]H 2 O PET study. Am J Psychiatry 2003; 160: 919-923. (Pubitemid 41079577)
24. LeDoux JE, Iwata J, Cicchetti P, Reis DJ: Different projections of the central amygdaloid nucleus mediate autonomic and behavioral correlates of conditioned fear. J Neurosci 1988; 8: 2517-2529.
25. Davis M: The role of the amygdala in fear and anxiety. Annu Rev Neurosci 1992; 15: 353-375.
26. Schaefer SM, Jackson DC, Davidson RJ, Aguirre GK, Kimberg DY, Thompson-Schill SL: Modulation of amygdalar activity by the conscious regulation of negative emotion. J Cogn Neurosci 2002; 14: 913-921.
27. Quirk GJ, Likhtik E, Pelletier JG, Pare D: Stimulation of medial prefrontal cortex decreases the responsiveness of central amygdala output neurons. J Neurosci 2003; 23: 8800-8807. (Pubitemid 37176661)
28. Berkowitz RL, Coplan JD, Reddy DP, Gorman JM: The human dimension: how the prefrontal cortex modulates the subcortical fear response. Rev Neurosci 2007; 18: 191-207.
29. Mathew SJ, Mao X, Coplan JD, Smith EL, Sackeim HA, Gorman JM, Shungu DC: Dorsolateral prefrontal cortical pathology in generalized anxiety disorder: a proton magnetic resonance spectroscopic imaging study. Am J Psychiatry 2004; 161: 1119-1121. (Pubitemid 38736002)
30. Osuch EA, Benson B, Geraci M, Podell D, Herscovitch P, McCann UD, Post RM: Regional cerebral blood flow correlated with flashback intensity in patients with posttraumatic stress disorder. Biol Psychiatry 2001; 50: 246-253. (Pubitemid 32778440)
31. Davidson RJ: Anxiety and affective style: role of prefrontal cortex and amygdala. Biol Psychiatry 2002; 51: 68-80. (Pubitemid 34093795)
32. Wager TD, Davidson ML, Hughes BL, Lindquist MA, Ochsner KN: Prefrontal-subcortical pathways mediating successful emotion regulation. Neuron 2008; 59: 1037-1050.
33. Allman JM, Hakeem A, Erwin JM, Nimchinsky E, Hof P: The anterior cingulate cortex. The evolution of an interface between emotion and cognition. Ann NY Acad Sci 2001; 935: 107-117. (Pubitemid 32511395)